Page 149 - FIGHT AGAINST UNCERTAINTY 5 FEB 2021

Research and Trials

Malaysia is also participating in a number of Research &
Development initiatives in COVID-19, including a clinical trial
on the treatment of tocilizumab for severe COVID-19 cases,
through the WHO-led SOLIDARITY trial which includes
remdesivir-based regimens, and through participating in the
Clinical Research Coalition (CRC) for COVID-19, which brings
together an array of health experts, including public-sector
research institutes, ministries of health, academia, not-for-profit
research and development organisations, NGOs, international
organisations, and funders which are all committed to finding
COVID-19 solutions for resource-poor settings.

MOH hospitals involved in the WHO-led SOLIDARITY trial are
Hospital Sungai Buloh, Hospital Kuala Lumpur Hospital and
Hospital Tuanku Jaafar, Seremban.

5. Report by New Straits Time, 13
5 6 April 2020 on clinical trials for
Tocilizumab in COVID-19 treatment
6. Joint News Release, 5 April 2020
on the Solidarity Trial launched by
WHO and Malaysia’s involvement

135